About
Company
Leadership
News
Events
Careers
Products
Aurora TX
Aurora
HaLCon
Apollo
View All Products
Services
Applications
Biophysical Characterization
Bioprocess Analytics
Resources
Symposium
App Notes
Publications
Webinars
Posters
Articles
Brochures
Videos
View All Resources
Technology
Our Technology
FAQs
Contact Us
Redshiftbio
News & Press
Sort
Date (Newest First)
Date (Oldest First)
Sort by Name (A - Z)
Sort by Name (Z - A)
Filter Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Showing
0
results of
0
items.
News & Press
May 13, 2024
RedShiftBio Launches Aurora TX: Revolutionizing RNA and Protein Analysis with Ultra-Sensitive Microfluidic Modulation Spectroscopy and Thermal Ramping Capability
Read more
News & Press
April 1, 2024
RedShiftBio Welcomes Sebastian Arevalo as New Sales Leader
Read more
News & Press
March 7, 2024
Tom O’Lenic joins RedShiftBio as Chief Executive Officer
Read more
News & Press
August 30, 2023
RedShift BioAnalytics’ HaLCon Analyzer Awarded Best of Show at the 15th Annual Bioprocessing Summit
Read more
News & Press
August 24, 2023
RedShift BioAnalytics Announces Distribution Agreement with Flownamics for The Director™ Liquid Handler.
Read more
News & Press
July 13, 2023
RedShift BioAnalytics Announces Launch of Aurora Second-Generation MMS Platform , for Ultra-Sensitive Biophysical Characterization of Biomolecules
Read more
News & Press
June 7, 2023
RedShift BioAnalytics Launches HaLCon™ Analyzer, ProvidingSimple and Accurate On-Demand Protein Titer Measurements for Bioprocess Development and Manufacturing
Read more
News & Press
May 17, 2023
RedShift BioAnalytics Announces Acquisition of Novel Liquid Chromatography Protein Analyzer Technology
Read more
News & Press
May 2, 2022
RedShift BioAnalytics Announces Launch of Next Generation Apollo for Ultra-Sensitive Biophysical Characterization of Biomolecules
Read more
News & Press
March 30, 2022
RedShift BioAnalytics announces partnership with DKSH, expanding the MMS market in Asia Pacific
Read more
News & Press
November 16, 2021
Strategic relationship between SCIEX and RedShiftBio® expands the reach of disruptive technology to address challenges with rapid secondary structure assessment of biotherapeutics
Read more
News & Press
October 18, 2021
RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures
Read more
News & Press
October 6, 2021
RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program
Read more
News & Press
September 7, 2021
RedShift BioAnalytics Appoints Amol Chaubal, CFO of Waters Corporation, to Board of Directors
Read more
News & Press
February 18, 2021
RedShift BioAnalytics Announces 500% Sales Growth in 2020 and Closing of Additional Financing
Read more
News & Press
October 15, 2020
RedShiftBio Expands Team to Support Demand for AQS³pro
Read more
News & Press
October 5, 2020
Peer-reviewed study demonstrates higher sensitivity, repeatability, and utility relative to conventional FTIR
Read more
News & Press
September 9, 2020
RedShiftBio’s AQS³pro Goes Global With Appointment of Spinco Biotech as Exclusive Indian Distributor
Read more
News & Press
June 16, 2020
RedShiftBio Appoints Primetech as Exclusive Distributor in Japan
Read more
News & Press
May 7, 2020
RedShiftBio Appoints Topbiox as Exclusive Distributor in China
Read more
News & Press
April 16, 2020
Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics
Read more
News & Press
January 29, 2020
RedShiftBio Appoints Julien Bradley as CEO and Closes $18M Series D Round Funding
Read more
News & Press
December 2, 2019
The AQS³pro - A Hit For The Second Year Running at PEGS Europe
Read more
News & Press
November 21, 2019
Accelerating Novel And Complex Modules Towards CMC Success
Read more
News & Press
November 20, 2019
MIBio 2019: A Huge Success for RedShiftBio
Read more
News & Press
October 21, 2019
Monitoring protein aggregation in biotherapeutics - a hot topic at the 9th annual American Drug Delivery & Formulation Summit
Read more
News & Press
August 23, 2019
Protein Aggregation Monitoring: Bioprocessing Summit 2019
Read more
News & Press
August 20, 2019
Researchers From Numerous Disciplines Gather At The Colorado Protein Stability Conference
Read more
News & Press
May 7, 2019
RedShiftBio’s AQS³pro Changes the Game in the Detection and Treatment of Alzheimer’s Disease
Read more
News & Press
April 23, 2019
Inspiring innovative biotherapeutic protein drug development at PEGS 2019
Read more
News & Press
April 23, 2019
Scientists See Change in Higher Order Structure with MMS at HOS 2019
Read more
News & Press
April 3, 2019
RedShiftBio Shipping AQS³pro as Industry Endorsements Expand
Read more
News & Press
March 13, 2019
Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit
Read more
News & Press
February 15, 2019
AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019
Read more
News & Press
February 15, 2019
RedShiftBio Shines at PepTalk 2019
Read more
News & Press
February 15, 2019
RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)
Read more
News & Press
January 31, 2019
RedShiftBio’s AQS³pro: Finalist in The Prism Awards 2019
Read more
News & Press
January 28, 2019
Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab
Read more
News & Press
December 14, 2018
RedShiftBio’s AQS³pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018
Read more
News & Press
October 31, 2018
American Pharmaceutical Review publishes article on MMS by Karan K. Shah Principal Development Associate Analytical and Pharmaceutical Sciences ImmunoGen, Inc.
Read more
News & Press
October 5, 2018
Complex Protein Studies Demand Dynamic Techniques: Article in Biopharma International
Read more
News & Press
August 26, 2018
Immunogen Presents MMS Data in Talk at Bioprocessing Summit 2018
Read more
News & Press
August 17, 2018
Workshop on Protein Aggregation and Immunogenicity 2018
Read more
News & Press
August 17, 2018
RedShiftBio Strengthens Focus on Applications with New Hire
Read more
News & Press
July 2, 2018
Spectroscopy North America publishes peer-reviewed paper on MMS from Brent Kendrick of Elion Labs, Eugene Ma and Libo Wang of RedShiftBio
Read more
News & Press
May 15, 2018
RedShiftBio Expands Team to Support Launch of FlagShip AQS³®pro System for Protein Characterization
Read more
News & Press
May 11, 2018
RedShiftBio Stole the Show at PEGS with the Launch of AQS³pro
Read more
News & Press
May 10, 2018
Instrument Business Outlook interviews RedShiftBio CCO Jeff Zonderman on the launch of the AQS³pro
Read more
News & Press
May 1, 2018
RedShiftBio Launches New Protein Characterization Instrument System - AQS³pro See Change™ with the new AQS³pro System for protein characterization from RedShiftBio.
Read more
News & Press
May 1, 2018
Spectroscopy Europe highlights the launch of the AQS³pro
Read more
News & Press
April 23, 2018
RedShiftBio presents MMS data at HOS 2018
Read more
News & Press
April 3, 2018
RedShiftBio at Biotherapeutics Analytical Summit 2018
Read more
News & Press
March 15, 2018
RedShiftBio Announces Collaboration Trial Completion ,Academic and Industrial Collaborators Validate New Bioanalytical Platform
Read more
News & Press
March 12, 2018
Biophysical Society: educating biophysicists on cutting edge technologies in protein characterization
Read more
News & Press
February 28, 2018
Celebrating new analytical techniques to accelerate the development of life saving biotherapeutics at PepTalk
Read more
News & Press
June 2, 2017
Jeffrey Zonderman Joins RedShiftBio as its Chief Commercial Officer
Read more
News & Press
March 15, 2017
RedShiftBio Inc. Completes $11.0 million Series C Financing
Read more
Unfortunately, we couldn't find any News Articles matching your criteria.
Load More
Request a Demo Today!
Contact Us
